The costs and consequences of omalizumab in uncontrolled asthma from a USA payer perspective (Q82865636)

From Wikidata
Jump to navigation Jump to search
scientific article published on 10 February 2010
edit
Language Label Description Also known as
English
The costs and consequences of omalizumab in uncontrolled asthma from a USA payer perspective
scientific article published on 10 February 2010

    Statements

    The costs and consequences of omalizumab in uncontrolled asthma from a USA payer perspective (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit